Eileen E. Ming
Impact in
- Family Practice top 2%
- Medication Adherence and Compliance
- Pharmacology top 5%
- Treatment of Major Depression
- Pharmacogenetics and Drug Metabolism
Papers in
- Surgery 7
- Lipoproteins and Cardiovascular Health 6
-
- Pharmacovigilance and Adverse Drug Reactions 2
- Co-authors
- Peter Paul Toth (1 shared paper)Danielle M. Potter (1 shared paper)Leona Enama Markson (2 shared papers)Enid M. Hunkeler (2 shared papers)Scott A. Bull (2 shared papers)Peter D. Eisenberg (1 shared paper)Henry X. Hu (1 shared paper)Carl A. de Moor (1 shared paper)
- Journals
- Pharmacoepidemiology and Drug Safety (4 papers)Journal of clinical lipidology (2 papers)The Journal of Clinical Psychiatry (2 papers)Supportive Care in Cancer (1 paper)JAMA (1 paper)
- Partner nations
- United StatesSwedenSpain
In The Last Decade
Eileen E. Ming
14 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Family Practice 95
- Pharmacology 159
- Surgery 440
- Geriatrics and Gerontology 34
- Pharmacology 71
Countries citing papers authored by Eileen E. Ming
This map shows the geographic impact of Eileen E. Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen E. Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen E. Ming more than expected).
Fields of papers citing papers by Eileen E. Ming
This network shows the impact of papers produced by Eileen E. Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen E. Ming. The network helps show where Eileen E. Ming may publish in the future.
Co-authors
The 25 scholars most cited alongside Eileen E. Ming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 308 | |
| 2 | 2006 | 274 | |
| 3 | 2012 | 223 | |
| 4 | 2004 | 194 | |
| 5 | 2016 | 98 | |
| 6 | 2004 | 59 | |
| 7 | 2010 | 58 | |
| 8 | 2000 | 50 | |
| 9 | 2006 | 49 | |
| 10 | 2008 | 39 | |
| 11 | 2012 | 19 | |
| 12 | 2009 | 8 | |
| 13 | 2006 | 5 | |
| 14 | Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries. | 2010 | 1 |
About Eileen E. Ming
Eileen E. Ming is a scholar working on Surgery, Toxicology, Pharmacology, Family Practice and Geriatrics and Gerontology, having authored 14 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Treatment of Major Depression (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Eating Disorders and Behaviors (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Blood Pressure and Hypertension Studies (1 paper) and Global Cancer Incidence and Screening (1 paper). The work is most often cited by research in Family Practice (95 citations), Pharmacology (159 citations), Surgery (440 citations), Geriatrics and Gerontology (34 citations) and Pharmacology (71 citations). Eileen E. Ming has collaborated with scholars based in United States, Sweden and Spain. Frequent co-authors include Peter Paul Toth, Danielle M. Potter, Leona Enama Markson, Enid M. Hunkeler, Scott A. Bull, Peter D. Eisenberg, Henry X. Hu, Carl A. de Moor, Lorenzo G. Cohen and BRUCE H. FIREMAN. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, Journal of clinical lipidology, The Journal of Clinical Psychiatry, Supportive Care in Cancer and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.